Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer
2016 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer
Wang, J. ; Yang, S.; He, P.; Schetter, A. J.; Gaedcke, J. ; Ghadimi, B. M. & Ried, T. et al. (2016)
Clinical Cancer Research, 22(24) pp. 5992-6001. DOI: https://doi.org/10.1158/1078-0432.CCR-16-0511
